Advertisement

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleBrain

A Whole-Brain Analysis in De Novo Parkinson Disease

C. Tessa, M. Giannelli, R. Della Nave, C. Lucetti, C. Berti, A. Ginestroni, U. Bonuccelli and M. Mascalchi
American Journal of Neuroradiology April 2008, 29 (4) 674-680; DOI: https://doi.org/10.3174/ajnr.A0900

References

  1. ↵
    Braak H, Ghebremedhin E, Rüb U, et al. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004;318:121–34
    CrossRefPubMedWeb of Science
  2. ↵
    Braak H, Rüb U, Jansen Steur EN, et al. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005;64:1404–10
    Abstract/FREE Full Text
  3. ↵
    Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort—The Parkinson Study Group. Neurology 1990;40:1529–34
    Abstract/FREE Full Text
  4. ↵
    Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol 2001;58:1611–15
    CrossRefPubMedWeb of Science
  5. ↵
    Korchounov A, Schipper HI, Preobrazhenskaya IS, et al. Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson's disease. Mov Disord 2004;19:1059–64
    CrossRefPubMed
  6. ↵
    Kang GA, Bronstein JM, Masterman DL, et al. Clinical characteristics in early Parkinson's disease in a central California population-based study. Mov Disord 2005;20:1133–42
    CrossRefPubMedWeb of Science
  7. ↵
    Schiess MC, Zheng H, Soukup VM, et al. Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis. Parkinsonism Relat Disord 2000;6:69–76
    CrossRefPubMedWeb of Science
  8. ↵
    Burton EJ, McKeith IG, Burn DJ, et al.. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004;127:791–800
    Abstract/FREE Full Text
  9. ↵
    Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol 2005;252:1345–52. Epub 2005 Jul 5
    CrossRefPubMedWeb of Science
  10. ↵
    Nagano-Saito A, Washimi Y, Arahata Y, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005;64:224–29
    Abstract/FREE Full Text
  11. ↵
    Summerfield C, Junqué C, Tolosa E, et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 2005;62:281–85
    CrossRefPubMedWeb of Science
  12. ↵
    Beyer MK, Janvin CC, Larses JP, et al. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 2007;78:254–59
    Abstract/FREE Full Text
  13. ↵
    Bowen BC, Block RE, Sanchez-Ramos J, et al. Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. AJNR Am J Neuroradiol 1995;16:61–68
    Abstract
  14. ↵
    Hu MT, Taylor-Robinson SD, Chaudhuri KR, et al. Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study. J Neurol Neurosurg Psychiatry 1999;67:20–26
    Abstract/FREE Full Text
  15. ↵
    Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994;14:783–801
    CrossRefPubMedWeb of Science
  16. Piert M, Koeppe RA, Giordani B, et al. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease. J Nucl Med 1996;37:1115–22
    Abstract/FREE Full Text
  17. Bohnen NI, Minoshima S, Giordani B, et al. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology 1999;52:541–46
    Abstract/FREE Full Text
  18. ↵
    Hu MT, Taylor-Robinson SD, Chaudhuri KR, et al. Cortical dysfunction in non-demented Parkinson's disease patients: a combined 31P-MRS and 18 FDG-PET study. Brain 2000;123:340–52
    Abstract/FREE Full Text
  19. ↵
    Abe Y, Kachi T, Kato T, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003;74:419–22
    Abstract/FREE Full Text
  20. ↵
    Oishi N, Udaka F, Kameyama M, et al. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 2005;65:1708–15
    Abstract/FREE Full Text
  21. ↵
    Bozzali M, Franceschi M, Falini A, et al. Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 2001;57:1135–37
    Abstract/FREE Full Text
  22. ↵
    Mascalchi M, Lolli F, Della Nave R, et al. Volumetric, diffusion and magnetization transfer MR imaging of the brain in individuals with Huntington's disease. Radiology 2004;232:867–73
    CrossRefPubMedWeb of Science
  23. ↵
    Della Nave R, Foresti S, Tessa C, et al. ADC mapping of neurodegeneration in the brainstem and cerebellum in patients with progressive ataxias. Neuroimage 2004;22:698–705
    CrossRefPubMed
  24. ↵
    Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust and automated longitudinal and cross-sectional brain changes analysis. Neuroimage 2002;17:479–89
    CrossRefPubMedWeb of Science
  25. ↵
    Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745–52
    Abstract/FREE Full Text
  26. ↵
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res 1975;12:189–98
    CrossRefPubMedWeb of Science
  27. ↵
    Fahn S, Elton RL, and members of the UPDRS development committee. The Unified Idiopathic Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information;1987 :153–64
  28. ↵
    Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–42
    FREE Full Text
  29. ↵
    Behrens TEJ, Woolrich MW, Jenkinson M, et al. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med 2003;50:1077–88
    CrossRefPubMedWeb of Science
  30. ↵
    Smith S, Jenkinson M, Woolrich M, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23:208–19
    CrossRef
  31. ↵
    Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5T in Alzheimer dementia and normal aging. AJNR Am J Neuroradiol 1987;8:421–26
    Abstract/FREE Full Text
  32. ↵
    Della Nave R, Magaudda A, Michelucci R, et al. Whole-brain histogram and voxel-based analyses of apparent diffusion coefficient and magnetization transfer ratio in celiac disease, epilepsy, and cerebral calcifications syndrome. AJNR Am J Neuroradiol 2007;28:479–85
    Abstract/FREE Full Text
  33. ↵
    Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation maximization algorithm. IEEE Trans Med Imaging 2001;20:45–57
    CrossRefPubMedWeb of Science
  34. ↵
    Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000;12:191–200
    CrossRefPubMedWeb of Science
  35. ↵
    Huber JB, Shuttleworth E, Christy JA, et al. Magnetic resonance imaging in dementia of Parkinson's disease. J Neurol Neurosurg Psychiatry 1989;52:1221–27
    Abstract/FREE Full Text
  36. ↵
    Laasko MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology 1996;46:678–81
    FREE Full Text
  37. Camicioli R, Moore MM, Kinney A, et al. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 2003;18:784–90
    CrossRefPubMedWeb of Science
  38. ↵
    Tam CW, Burton EJ, McKeith IG, et al. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 2005;8:861–65
  39. ↵
    Brück A, Kurki T, Kaasinen V, et al. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J Neurol Neurosurg Psychiatry 2004;75:1467–69
    Abstract/FREE Full Text
  40. ↵
    Hu MT, White SJ, Chaudhuri KR, et al. Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm 2001;108:571–78
    CrossRefPubMedWeb of Science
  41. ↵
    Burton EJ, McKeith IG, Burn DJ, et al. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord 2005;20:1571–76
    CrossRefPubMed
  42. ↵
    Seppi K, Schocke MF, Esterhammer R, et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology 2003;60:922–27
    Abstract/FREE Full Text
  43. Schocke MF, Seppi K, Esterhammer R, et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 2004;21:1443–51
    CrossRefPubMedWeb of Science
  44. Nicoletti G, Lodi R, Condino F, et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson's variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006;129:2679–87
    Abstract/FREE Full Text
  45. Paviour DC, Thornton JS, Lees AJ, et al. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Mov Disord 2007;22:68–74
    CrossRefPubMedWeb of Science
  46. ↵
    Köllensperger M, Seppi K, Liener C, et al. Diffusion weighted imaging best discriminates PD from MSA-P: a comparison with tilt table testing and heart MIBG scintigraphy. Mov Disord 2007;22:1771–76
    CrossRefPubMed
  47. ↵
    Scherfler C, Schocke MF, Seppi K, et al. Voxel-wise analysis of diffusion-weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain 2006;129:538–42
    Abstract/FREE Full Text
  48. ↵
    Rovaris M, Iannucci G, Sormani MP, et al. Age-related changes in conventional, magnetization transfer and diffusion-tensor MR imaging findings: study with whole-brain tissue histogram analysis. Radiology 2003;227:731–38
    PubMedWeb of Science
  49. ↵
    Zivadinov R, Grop A, Sharma J, et al. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole brain atrophy measurements in multiple sclerosis. J Neuroimaging 2005;15:27–36
    CrossRefPubMedWeb of Science
  50. ↵
    Smith SM, Rao A, De Stefano N, et al. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX. Neuroimage 2007;36:1200–06. Epub 2007 Apr 27
    CrossRefPubMedWeb of Science
  51. ↵
    Peters N, Holtmannspotter M, Opherk C, et al. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology 2006;66:1517–22
    Abstract/FREE Full Text
  52. ↵
    Cercignani M, Inglese M, Pagani E, et al. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001;22:952–58
    Abstract/FREE Full Text
  53. ↵
    Della Nave R, Foresti S, Pratesi A, et al. Whole-brain histogram and voxel-based analyses of diffusion tensor imaging in patients with leukoaraiois: correlation with motor and cognitive impairment. AJNR Am J Neuroradiol 2007;28:1313–19
    Abstract/FREE Full Text
  54. ↵
    Jellinger KA. Post-mortem studies in Parkinson's disease: is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 1999;56:1–26
    PubMed
  55. ↵
    Jellinger KA. Recent developments in the pathology of Parkinson's disease. J Neural Trans Suppl 2002;62:347–46
  56. ↵
    Alves G, Larsen JP, Emre M, et al. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006;21:1123–30
    CrossRefPubMed
  57. ↵
    Burn DJ, Rowan EN, Allan LM, et al. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006;77:585–89
    Abstract/FREE Full Text
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Cite this article
0 Responses
Respond to this article
Bookmark this article
A Whole-Brain Analysis in De Novo Parkinson Disease
C. Tessa, M. Giannelli, R. Della Nave, C. Lucetti, C. Berti, A. Ginestroni, U. Bonuccelli, M. Mascalchi
American Journal of Neuroradiology Apr 2008, 29 (4) 674-680; DOI: 10.3174/ajnr.A0900
del.icio.us logo Twitter logo Facebook logo Mendeley logo
Purchase

Jump to section

Advertisement